|
Andrews, NC. Anemia of inflammation: the cytokine-hepcidin link.J.Clin. Invest. 2004; 113, 1251–1253. Ashkenzi A, Dixit, VM. Death receptor: signaling and modulation.Science 218. 1998; 1305-1308. Badley AD, McElhinny JA, Leibson PJ, Lynch DH, Alderson MR, Paya,CV. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J.Virol. 1996; 70:199-206. Baker MA, Maloy WL, Zasloff M, Jacob LS. Anticancer efficacy of Magainin2 and analogue peptides. Cancer Res.1993;53:3052–7. Bechinger B., Lohner K. Detergent-like actions of linear amphipathic cationic antimicrobial peptides. BBA Biomembranes. 2006;1758:1529–1539. Bortner CD, Cidlowski JA. Celluar mechanisms for the repression of apoptosis. Ann.Rev.Pharmacol.Toxicol. 2002; 42:259-281 Bowdish DM, Davidson DJ, Lau YE, Lee K, Scott MG, Hancock RE. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 2005; 77:451–459. Brown DG, Sun XM, Cohen GM. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragment prior internucleosomal fragmentation. J. Biol. Chem. 1993; 268: 3037-3039. Brown KL, Hancock RE. Cationic host defense (antimicrobial) peptides. Curr. Opin. Immunol. . 2006; 18:24–30. Burick MD, Harris A, Reid CJ, Iwamura T, Hollingsworth MA: Oligosaccharides expressed on MUC1by pancreatic and colon tumor cell lines. J. Biol. Chem. 1997; 272:24198-24202. 49 Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nature Reviews. 2002; 2, 563-572. Chan YR, Gallo RL. PR-39, a syndecan-inducing antimicrobial peptide, binds and affects p130(Cas). J. Biol. Chem. 1998; 273:28978–28985. Chaudhary J, Munshi M. Scanning electron microscopic analysis of breast aspirates. Cytopathology .1995 ; 6:162-167. Chen Y, Xu X, Hong S, Chen J, Liu N, Underhill CB, Creswell K, Zhang L. RGD-Tachyplesin inhibits tumor growth. Cancer Res. 2001;61:2434–8. Chertov O, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, Longo D L, Taub DD, Oppenheim JJ. Identification of defensin-1,defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 1996; 271:2935–2940. Cunliffe RN, Mahida YR. Expression and regulation of antimicrobial peptides in the gastrointestinal tract. J. Leukoc. Biol. 2004; 75:49–58. Davidson DJ, Currie AJ, Reid GS, Bowdish DM, MacDonald KL, Ma RC, Hancock RE, Speert DP. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cellinduced T cell polarization. J. Immunol. 2004; 172:1146–1156. Devine DA, Hancock REW. Cationic peptides: Distribution and mechanism of resistance. Curr Pharm Design. 2002 ;8:703–714. Dobrzynska I, Szachowicz-Petelska B, Sulkowski S, Figaszewski Z: Changes in electric charge and phospholipids composition in human colorectal cancer cells. Mol. Cell. Biochem.2005; 276:113-119. Domagala W, KossLG. Surface configuration of human tumor cells obtained by fine needle aspiration biopsy. Scan. Electron Microsc. 1980; 1:101-108. 50 Ellerby HM, Arap W, Ellerby LM, Kain R, Andrusiak R, Rio GD, Krajewski S, Lombardo CR, Rao R, Ruoslahti E, Bredesen DE, Pasqualini R. Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med. 1999; 5:1032–8. Elsbach P. What is the real role of antimicrobial polypeptides that can mediate several other inflammatory responses J. Clin. Investig. 2003; 111:1643–1645. Fehsel K, Kolb-Bachofen V, and Klaus-Dietrich Kröncke. Necrosis is the predominant type of islet cell death during development of insulin-dependent diabetes mellitus in BB rats. Laboratory Investigation. 2003; 83(4):549-59 Folkman J. Tumor angiogensis: role in regulation of tumor growth. Symp Soc Dev Biol. 1974; 30(0):43-52. Frederick L. Greene, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M. AJCC Cancer Staging Manual, 6th Edition. 2002; American Joint Committee on Cancer. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood . 2003; 102, 783–788 Giuliani A, Pirri G, Nicoletto SF. Antimicrobial peptides: an overview of a promising class of therapeutics. Cen Eur J Biol 2007;2:1–33. Gjertsen BT, Logothetis CJ, McDonnell TJ. Molecular regulation of cell death and therapeutic strategies for cell death induction in prostate carcinoma. Cancer Metastasis Rev. 1998;17:345–51. Green DR, Reed JC. Mitochondrial and apoptosis . Science. 1998;281:1309-1312. Hale AJ, Smith CA, Sutherland LC, Stonaman VE, Longthorne V, Culhane AC, Williams GT. Apoptosis: molecular regulation of cell death. Proc.Natl.Acad.Sci.USA. 1996; 93:2774-2778. 51 Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100 (1): 57–70. Hallock KJ, Lee DK, Ramamoorthy A. MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain. Biophys J ; 2003;84:3052. Hancock RE. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 2001; 1:156–164. Hancock RE, Lehrer R. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 1998; 16:82–88. Henzler Wildman KA, Lee DK, Ramamoorthy A. Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. Biochemistry . 2004; 42:6545–6558. Howell MD, Wollenberg A,Gallo RL, Flaig M, Streib JE, Wong C, Pavicie T, Boguniewicz M, Leung DY. Cathelicidin deficiency predisposs to eczema herpeticum. J. Allergy Cli. Immunol. 2006 117 (4):836-841 Hoskin DW, Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta. 2008;1778(2):357–75 Huang GT, Zhang HB, Kim D, Liu L, Ganz T. A model for antimicrobial gene therapy: demonstration of human beta-defensin 2 antimicrobial activities in vivo. Human Gene THerap. 2002; 13 (17): 2017-2025. Huang PH, Chen JY, Kuo CM. Three different hepcidins from tilapia, Oreochromis mossambicus: Analysis of their expressions and biological functions, Molecular Immunology 44 .2007; 1922–193. Mader JS, Hoskin DW. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment.. Expert Opin. Investig. Drugs. 2006; 15(8):933-946. 52 Jemmerson R, LaPlante B, Treeful A. Release of intact monomeric cytochrome c from apoptosis and necrosis cell. Cell Death Differ. 2002; 9:538-548. Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem. 1998; 273:3718–24. Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol. 2007;8:931-7. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implication in tissue kinetics. Br.J.Cancer. 1972; 26:239-257. Koczulla RG, von Degenfeld C, Kupatt F, Krotz S, Zahler T, Gloe K, Issbrucker P, Unterberger M, Zaiou C, Lebherz A, Karl P, Raake A, Pfosser P, Boekstegers U, Welsch PS, Hiemstra C, Vogelmeier RL, Gallo M, Clauss M, Bals R. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Investig. 2003; 111:1665–1672. Korzeniewski C, Callewaert DM. J. Immunol. Methods. 1983; 64(3):313–320. Koczulla AR, Bals R. Antimicrobial peptides – current status and therapeutics potential. Drugs . 2003;63:389–406. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe, P, Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000; 480, 147–150. Kroemer G, Jaattela M. Lysosomes and autophagy in cell death control. Nat Rev Cancer .2005;5:886-97. 53 Kroemer G, Dalla B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physicol. 1998; 60: 619-42. Legrand C, Bour JM, Jacob C, Capiaumont J, Martial A, Marc A, Wudtke M, Kretzmer G, Demangel C Duval D. Lactate dehydrogenase (LDH) activity of the cultured eukaryotic cells as marker of the number of dead cells in the medium. J Biotechnol. 1992; 25(3):231-43. Levine B, Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol. 2007; 7:767-77. Levine B, Abrams J. p53: The Janus of autophagy? . Nat Cell Biol . 2008;10:637-9. Lin WJ, Chien YL, Pan CY, Lin TL, Chen JY, Chiu SJ, Hui CF. Epinecidin-1, an antimicrobial peptide from fish (Epinephelus coioides) which has an antitumor effect like lytic peptides in human fibrosarcoma cells. Peptide 30. 2009; 1636–1642. LorenzoHK, Susin SA, Penninger J, Kroemer G. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death.Deffer. 1999; 6:516-524. Mai JC, Mi Z, Kim SH, Ng B, Robbins PD. A proapoptotic peptide for the treatment of solid tumors. Cancer Res. 2001;61:7709–12. Martin E, Ganz T, Lehrer RI. Defensins and other endogenous peptide antibiotics of vertebrates. J. Leukoc. Biol. 1995; 58:128–136. Matyus E, Kandt C, Tieleman DP. Computer simulation of antimicrobial peptide. Curr. Med. Chem.2007; 14(26): 2789-2798. Matsuzaki K, Murase O, Fujii N, Miyajima K. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry. 1996; 35:11361–11368. 54 Miteva M, Anderson M, Karshikoff A, Otting G. Molecular electrophoration: a unifying concept for the description of membrane pore formation by antibacterial peptides, exemplified with NK-lysin. FEBS Lett. 1999;462:155–158. Modur V, Nagarajan R, Evers BM, Milbrandt J. FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J Biol Chem. 2002; 277:47928–37. Mor A. Peptide-based antibiotics: A potential answer to raging antimicrobial resistance. Drug dev Res. 2000; 50:440–447. Munshi A, McDonnell TJ, Meyn RE. Chemotherapeutic agents enhance TRAILinduced apoptosis in prostate cancer cells. Cancer Chemother Pharmacol .2002;50:46–52. Oren Z, Shai Y. Mode of action of linear amphipathic ãhelical antimicrobial peptides. Biopolymers. 1998;47:451–463. Park, CH, Valore, EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 2001; 276:7806–7810. Richard S. Hotchkiss MD, Andreas Strasser Ph.D., Jonathan E. McDunn, Ph.D., Paul E, Swanson MD. Mechanisms of Disease Cell Death. The new England journal o f medicine.2009; 361:1570-83. Pkorny A, Almeida PFF. Kinetics of dye efflux and lipid flip-flop induced by delta-lysin in phosphatidylcholine vesicle and the mechanism of graded release by amphipathic, alpha-helical peptides. Biochemistry. 2004; 43:8846–8857. Rakoff-Nahoum S. Why Cancer and Inflammation? YALE JOURNAL OF BIOLOGY AND MEDICINE 79. 2006; pp.123-130. Reed JC, Tomaselli KJ. Drug discovery opportunities from apoptosis 55 research . Curr.Opin.Biotechnol. 2000; 11:586-592. Rosenfeld Y, Shai Y. Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: Role in bacterial resistance and prevention of sepsis. BBA-Biomembranes. 2006;1758:1513–1522. Saraste A, Pulkki K. Morphologic and biochemical hallmark of apoptosis. Cardiovasc. Res. 2000; 45:528-537. Samali A, Gorman AM, Cotter G. Apoptosis-he story so far-. Exprientia. 1996; 52(10-11): 933-941. Schwartzman RA, Cidlowski JA. Apoptosis: the biochemistry and molecular biology of progression cell death. Endocr.Rev. 1993; 14;133-151. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta.1999; 1462:55–70. Shai Y. Model of action of membrane active antimicrobial peptide. Biopolymer. 2000: 66: 236-248. Suttmann H, Retz M, Paulsen F, Harder J, Zwergel U, Kamradt J, et al. Antimicrobial peptides of the cecropinfamily show potent antitumor activity against bladder cancer cells. BMC Urol. 2008;8:5. Territo MC, Ganz T, Selsted ME, Lehrer R. Monocytechemotactic activity of defensins from human neutrophils. J. Clin. Investig.1989; 84:2017–2020. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995; 267:1456-1462. Utsug T, Schroit AJ, Connor J, Bucana CD, Fidler IJ: Elevated expression of phosphatidylserine in the outer leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer 56 Res. 1991; 51:3062-3066. Vyoral D, Petrak J. Hepcidin: a direct link between iron metabolism and immunity. Int. J. Biochem. Cell. Biol. 2005; 37, 1768–1773. Wang Z, and Wang G. APD: the Antimicrobial Peptide Database. Nucleic Acids Res. 2004; 32:D590–D592. Wang YD, Kung CW, Chen JY. Antiviral activity by fish antimicrobial peptides of epinecidin-1 and hepcidin 1–5 against nervous necrosis virus in medaka. Peptides 31. 2010; 1026–1033. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood . 2002; 100, 3776–3781 Yoon WH, Park HD, Lin K, Hwang BD: Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells. Biochem. Biophys.Res. Commun. 1996: 222:694-699. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415:389–395. Zasloff M. Trypsin, for the defense. Nat Immunol . 2002; 3:508–10.
|